Edarbyclor
Generic: Azilsartan Kamedoxomil And Chlorthalidone
Thiazide-like Diuretic✓ FDA-verified
View full FDA label ↗Edarbyclor is a medication used to treat high blood pressure, helping to lower the risk of serious heart-related issues like strokes and heart attacks. It works by blocking certain substances in your body that cause blood vessels to tighten, allowing blood to flow more easily. You take it as a tablet once a day, starting with a dose of 40/12.5 mg, which can be increased to a maximum of 40/25 mg if needed. It's important to know that Edarbyclor should not be taken if you have severe kidney problems, and it should not be used with certain diabetes medications that contain aliskiren. Always talk to your doctor about any other medications you are taking, especially if they include aliskiren, as this can lead to serious side effects.
✦
Uses
- Hypertension.
◷
Dosage
Starting dose is 40/12.5 mg once daily.
May increase to 40/25 mg after 2 to 4 weeks if needed.
Can be taken with or without food.
May be used with other blood pressure medications.
Always follow your doctor's specific instructions for your dose.
⚠
Side effects
Common
Common side effects include dizziness and fatigue
Serious
Serious side effects may include low blood pressure and kidney problems
🛑
Warnings
⚠ Important warnings
- Discontinue if pregnancy is detected due to fetal toxicity risk.
- Monitor for low blood pressure in volume-depleted patients.
- Risk of kidney function impairment.
- May cause low potassium levels.
- Use caution with other medications affecting blood pressure.
⇄
Drug interactions
- Lithiumincreased risk of toxicityMonitor
- NSAIDsmay reduce blood pressure effectCaution
- Dual RAS inhibitorsincreased risk of kidney issues.Monitor
Ask about this drug
Answers pulled from the FDA label only.
Medical Disclaimer: This content is provided for informational and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before taking any medication.
Data Source: Publicly available drug labeling information from the U.S. Food and Drug Administration (FDA).
Data Source: Publicly available drug labeling information from the U.S. Food and Drug Administration (FDA).
MedDataTool